SCHEMBL30342973

SCHEMBL30342973

Oc1ccc(Cl)cc1C=Nc1cccc(Cl)c1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.65
▸ KMT2A Q03164 4/20 0.55
▸ KDM4E B2RXH2 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ MAPT P10636 2/20 0.55
▸ HPGD P15428 2/20 0.55
▸ LMNA P02545 2/20 0.55
▸ HTT P42858 1/20 0.55
▸ HSD17B10 Q99714 3/20 0.48
▸ CASP1 P29466 3/20 0.48
▸ CA12 O43570 2/20 0.48
▸ CA2 P00918 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ GUSB P08236 1/20 0.48
▸ CYP2D6 P10635 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ GAA P10253 2/20 0.46
▸ TAAR1 Q96RJ0 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAOB P27338 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4348747 0.85 ALDH1A1 (0.79) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL4348745 0.85 ALDH1A1 (0.79) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL30342959 0.85 SMN1; SMN2 (0.57) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL30342529 0.84 MEN1 (0.52) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL9273922 0.83 CA12 (0.68) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL9273920 0.83 CA12 (0.68) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL9784134 0.82 ALDH1A1 (0.65) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL18717408 0.81 ALDH1A1 (0.60) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL11413435 0.81 ALDH1A1 (0.63) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL11413438 0.81 ALDH1A1 (0.63) ALDH1A1KMT2AKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129015-A1 HALOGENATED BENZYLIDINE DERIVATIVES Renovel Innovations, Inc. (US) 2025-04-24 — — US claimed
US-20230107812-A1 HALOGENATED BENZYLIDINE DERIVATIVES Renovel Innovations, Inc. 2023-04-06 — — US claimed
US-20250129015-A1 HALOGENATED BENZYLIDINE DERIVATIVES Renovel Innovations, Inc. (US) 2025-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129015-A1 HALOGENATED BENZYLIDINE DERIVATIVES BRD2, MPO, BRD9 ALDH1A1 1995/4885KMT2A 1147/4885KDM4E 1650/4885
US-20230107812-A1 HALOGENATED BENZYLIDINE DERIVATIVES BRD2, MPO, BRD9 ALDH1A1 1995/4885KMT2A 1147/4885KDM4E 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback